Related Experiment Video

Updated: Mar 20, 2026

Whole-mount Immunohistochemical Analysis for Embryonic Limb Skin Vasculature: a Model System to Study Vascular Branching Morphogenesis in Embryo
09:53

Whole-mount Immunohistochemical Analysis for Embryonic Limb Skin Vasculature: a Model System to Study Vascular Branching Morphogenesis in Embryo

Published on: May 20, 2011

18.2K

EphrinB2/EphB4 pathway in postnatal angiogenesis: a potential therapeutic target for ischemic cardiovascular disease

Du Yang1, Chunna Jin1, Hong Ma1

  • 1Department of Cardiology, Cardiovascular Key Laboratory of Zhejiang Province, The Second Affiliated Hospital, Zhejiang University School of Medicine, 88# Jiefang Road, Hangzhou, 310009, Zhejiang, China.

Angiogenesis
|May 25, 2016
PubMed

Insights

Investigating the EphrinB2/EphB4 pathway in angiogenesis is crucial for developing new treatments for ischemic cardiovascular disease. Understanding this pathway

Area of Science:

  • Cardiovascular Research
  • Molecular Biology
  • Vascular Biology

Background:

  • Ischemic cardiovascular disease is a major global health burden.
  • Current proangiogenic therapies show limited efficacy due to complex angiogenesis mechanisms.
  • Functional vessel formation is key to rescuing ischemic cardiomyocytes.

Purpose of the Study:

  • To review the role of the EphrinB2/EphB4 pathway in postnatal angiogenesis within ischemic cardiovascular disease.
  • To elucidate the mechanisms of EphrinB2/EphB4 in angiogenesis and its interactions with other angiogenic pathways.
  • To highlight the therapeutic potential of targeting the EphrinB2/EphB4 pathway for ischemic heart conditions.

Main Methods:

  • Literature review focusing on EphrinB2/EphB4 pathway in postnatal angiogenesis.
  • Analysis of existing preclinical and clinical trial data.
  • Synthesis of current knowledge on EphrinB2/EphB4 interactions with other angiogenic factors.

Main Results:

  • The EphrinB2/EphB4 pathway is critical for both microvascular growth and neovascular maturation.
  • Existing research has primarily focused on embryonic vascular development, with limited data on its role in ischemic heart disease.
  • Understanding EphrinB2/EphB4 interactions is essential for advancing therapeutic strategies.

Conclusions:

  • The EphrinB2/EphB4 pathway represents a promising target for novel therapeutics in ischemic cardiovascular disease.
  • Further research is needed to fully illustrate the pathway's role in postnatal angiogenesis in the ischemic heart.
  • Targeting EphrinB2/EphB4 may enhance the development of functional vessels and improve outcomes for patients.
Keywords:
AngiogenesisEphrinB2/EphB4 pathwayIschemic cardiovascular diseaseVEGF-Dll4/Notch-EphrinB2 cascadeVessel maturation

More Related Videos

Retinal Explant of the Adult Mouse Retina as an Ex Vivo Model for Studying Retinal Neurovascular Diseases06:51

Retinal Explant of the Adult Mouse Retina as an Ex Vivo Model for Studying Retinal Neurovascular Diseases

Published on: December 9, 2022

5.5K
In Vitro Model of Coronary Angiogenesis08:03

In Vitro Model of Coronary Angiogenesis

Published on: March 10, 2020

8.6K

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.9K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.8K
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
7.5K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
4.8K
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
537